Systematic Review
Published on 02 May 2024
Efficacy and safety of PD-1/PD-L1 inhibitor-based immune combination therapy versus sorafenib in the treatment of advanced hepatocellular carcinoma: a meta-analysis
in Gene and Cell Therapy
- 1,530 views
- 1 citation